Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.7650
+0.0680 (9.76%)
At close: Sep 1, 2026, 4:00 PM EDT
0.6885
-0.0765 (-10.00%)
Pre-market: Sep 2, 2026, 4:00 AM EDT
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $31.25 million as of September 1, 2026. Its market cap has decreased by -31.48% in one year.
Market Cap
31.25M
Enterprise Value
-17.75M
1-Year Change
-31.48%
Ranking
Category
Stock Price
$0.77
ChartMarket Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $31.25M, a decrease of -94.60%. That is a compound annual growth rate of -42.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 31.25M | 9.32% |
| Dec 31, 2025 | 28.59M | -41.18% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Estrella Immunopharma | 31.54M |
| Kyntra Bio | 31.50M |
| Radiopharm Theranostics | 31.12M |
| IGC Pharma | 30.93M |
| NextCure | 29.25M |
| CEL-SCI | 28.49M |
| NanoViricides | 28.48M |
| Polyrizon | 27.16M |